Lyso-Gb3 may have a role in glomerular injury in FD by promoting the release of secondary mediators of glomerular injury (Transforming growth factor-beta1 (TGF-β1) and the macrophage inhibitory factor receptor CD74) common to diabetic nephropathy [284]. This evidence concerns the gene TGFB1 and Fabry disease.